You have 9 free searches left this month | for more free features.

DEGARELIX

Showing 26 - 50 of 142

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Cancer Trial in Los Angeles (degarelix, enzalutamide, trametinib)

Active, not recruiting
  • Prostate Cancer
  • degarelix
  • +3 more
  • Los Angeles, California
    University of California, Los Angeles
Aug 25, 2022

Prostate Cancer, Stage IV Prostate Cancer Trial in Tampa (Luteinizing Hormone Releasing Hormone, New Hormonal Agent, Docetaxel)

Recruiting
  • Prostate Cancer
  • Stage IV Prostate Cancer
  • Luteinizing Hormone Releasing Hormone
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Jun 1, 2022

Prostate Cancer Metastatic Trial in New York (REGN2810, Degarelix, Leuprolide Acetate)

Recruiting
  • Prostate Cancer Metastatic
  • New York, New York
    Columbia University Irving Medical Center
Mar 22, 2022

Prostate Cancer Trial in India (Degarelix)

Completed
  • Prostate Cancer
  • Degarelix
  • Bikaner, Rajasthan, India
  • +18 more
Dec 14, 2021

Cognitive Impairment, Estrogen Deficiency, Menopause Trial in Aurora, Boulder (GnRHant + E2, GnRHant + Placebo)

Completed
  • Cognitive Impairment
  • +4 more
  • GnRHant + E2
  • GnRHant + Placebo
  • Aurora, Colorado
  • +1 more
Jun 3, 2021

Prostate Cancer, Neoadjuvant Therapy, Androgen Antagonists Trial in Leuven (ARN-509, Degarelix, Placebo)

Recruiting
  • Prostate Cancer
  • +3 more
  • Leuven, Vlaams-brabant, Belgium
    University Hospitals Leuven
Dec 23, 2020

Prostate Cancer Trial in Shanghai (drug, procedure, radiation)

Recruiting
  • Prostate Cancer
  • Leuprolide acetate
  • +9 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 15, 2022

Stage IV Prostate Cancer Trial in Baltimore (procedure, drug, other, biological)

Completed
  • Stage IV Prostate Cancer
  • Cryosurgery
  • +3 more
  • Baltimore, Maryland
    Johns Hopkins University/Sidney Kimmel Cancer Center
Nov 11, 2021

Effect of ADT in Prostate Cancer Asia (READT Asia Study)

Recruiting
  • Prostate Cancer
  • Androgen deprivation therapy - bilateral orchidectomy
  • +2 more
  • Shatin, Hong Kong
    Prince of Wales Hospital
Dec 14, 2021

Prostate Adenocarcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in Stanford (radiation, drug, other)

Active, not recruiting
  • Prostate Adenocarcinoma
  • +4 more
  • Internal Radiation Therapy
  • +7 more
  • Stanford, California
    Stanford University, School of Medicine
Feb 1, 2022

Pregnancy, Ovarian Trial in ThessalonĂ­ki (Degarelix)

Recruiting
  • Pregnancy, Ovarian
  • Degarelix
  • ThessalonĂ­ki, Greece
    Assisting Nature
Oct 6, 2020

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte

Recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +4 more
  • Abiraterone Acetate
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Oct 7, 2022

Prostate Cancer Trial in United States (Degarelix, stereotactic body radiosurgery (SBRT))

Active, not recruiting
  • Prostate Cancer
  • Degarelix
  • stereotactic body radiosurgery (SBRT)
  • Miami, Florida
  • +9 more
Mar 1, 2022

Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Houston (Abiraterone Acetate, Bicalutamide, Degarelix)

Active, not recruiting
  • Prostate Adenocarcinoma
  • Recurrent Prostate Carcinoma
  • Abiraterone Acetate
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Replication of PRONOUNCE Prostate Cancer Trial in Healthcare

Active, not recruiting
  • Prostate Cancer
  • Boston, Massachusetts
    Brigham and Women's Hospital
May 18, 2021

Prostatic Tumors Trial in Korea, Republic of (Leuprorelin, Goserelin, Triptorelin)

Recruiting
  • Prostatic Neoplasms
  • Cheongju, Korea, Republic of
  • +9 more
Jul 28, 2021

Prostate Cancer Trial in Turku (GnRH antagonist)

Recruiting
  • Prostate Cancer
  • GnRH antagonist
  • Turku, Finland
    Turku University Hospital
Apr 8, 2021

Prostate Adenocarcinoma Trial in Duarte (drug, radiation, other)

Recruiting
  • Prostate Adenocarcinoma
  • Leuprolide Acetate
  • +5 more
  • Duarte, California
    City of Hope Medical Center
Sep 14, 2022

Prostatic Tumors Trial in London, Ottawa, Toronto (Degarelix)

Terminated
  • Prostatic Neoplasms
  • Degarelix
  • London, Ontario, Canada
  • +2 more
May 5, 2020

Prostate Cancer Trial in Abbottsford, Surrey, Vancouver (Degarelix)

Completed
  • Prostate Cancer
  • Degarelix
  • Abbottsford, British Columbia, Canada
  • +2 more
Jan 23, 2020

Prostate Cancer, Oligometastasis, Oligorecurrence Trial in United States (procedure, radiation, other, drug)

Recruiting
  • Prostate Cancer
  • +4 more
  • PET-directed Local Therapy using Surgery
  • +10 more
  • Long Beach, California
  • +15 more
Jul 29, 2022

Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma, Oligometastatic Prostate Carcinoma Trial in Houston

Withdrawn
  • Biochemically Recurrent Prostate Carcinoma
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 14, 2021

Adenocarcinoma of Prostate Trial in France (Degarelix, Pelvic Radiotherapy)

Active, not recruiting
  • Adenocarcinoma of Prostate
  • Degarelix
  • Pelvic Radiotherapy
  • Angers, France
  • +38 more
May 11, 2022

Hormone Sensitive Prostate Cancer, Prostate Cancer, Cardiac Event Trial in Petah Tikva (Degarelix, GnRH agonist)

Unknown status
  • Hormone Sensitive Prostate Cancer
  • +2 more
  • Degarelix
  • GnRH agonist
  • Petah Tikva, Israel
    Rabin Medical Center - Beilinson Hospital
Nov 27, 2019